Sign in to view content

Clinical Effects of Blocking Ang-2 and VEGF with Faricimab in the Phase 2 STAIRWAY Trial

Carl J Danzig, MD

Video
Published 2020

Related

Protocol U: Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involv
Raj K. Maturi, MD
Updates from the Field
2017
20+ Years of The DRCR Network: What We Have Learned About Diabetic Retinopathy
John W. Kitchens, MD
Updates from the Field
2025
Staring a Clinical Trials Program
David A. Eichenbaum, MD, FASRS
Updates from the Field
2019

Category: AMD-Neovascular

See more